Ev-Marie Schuster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ev-Marie Schuster has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Schubert
Institute for Computational Biology, Helmholtz Zentrum München
2 shared publications Bernd Spriewald
Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
2 shared publicationsChristine Schülein
Mikrobiologisches Institut–Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2 shared publications- Dirk H. Busch
Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, Technical University of Munich, Munich, Germany
2 shared publications - Kilian Schober
Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany
2 shared publications Aikaterini Polyzou
International Max Planck Research School for Immunobiology, Epigenetics and Metabolism (IMPRS-IEM), Freiburg, Germany
1 shared publication
Latest Publications
- Open Access
- 24 February 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (3) , 452-462
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory
Metabolic activity shapes cell fate but remains challenging to capture in vivo with high resolution. Here we performed longitudinal metabolic and phenotypic profiling of human antigen-specific CD8 + T cells after yellow fever vaccination using flow cytometry and single-cell RNA sequencing. As assessed by protein translation rates, CD8 + T cells upregulated glycolysis to fuel anabolic needs for proliferation but predominantly used oxidative phosphorylation for energy production during the acute phase (days 7–28) after vaccination. Simultaneously, CD8 + CD62L + CD45RA − central memory T cells were the most metabolically active subset, whereas CD8 + CD62L − CD45RA + effector T cells underwent metabolic shutdown. Weakly differentiated CD8 + CD62L + CD45RA + CD95 − naive-like memory T cells showed minimal activity, relied solely on oxidative phosphorylation and were preferentially maintained 26 years postvaccination, reinforcing the link between cellular quiescence and longevity. Our study highlights quiescence as a key feature for long-term immunological memory formation in humans.
- 24 February 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (3) , 452-462
Open AccessMetabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory
Metabolic activity shapes cell fate but remains challenging to capture in vivo with high resolution. Here we performed longitudinal metabolic and phenotypic profiling of human antigen-specific CD8 + T cells after yellow fever vaccination using flow cytometry and single-cell RNA sequencing. As assessed by protein translation rates, CD8 + T cells upregulated glycolysis to fuel anabolic needs for proliferation but predominantly used oxidative phosphorylation for energy production during the acute phase (days 7–28) after vaccination. Simultaneously, CD8 + CD62L + CD45RA − central memory T cells were the most metabolically active subset, whereas CD8 + CD62L − CD45RA + effector T cells underwent metabolic shutdown. Weakly differentiated CD8 + CD62L + CD45RA + CD95 − naive-like memory T cells showed minimal activity, relied solely on oxidative phosphorylation and were preferentially maintained 26 years postvaccination, reinforcing the link between cellular quiescence and longevity. Our study highlights quiescence as a key feature for long-term immunological memory formation in humans.
- Open Access
Antigen receptor competition in CAR-TCR cells changes cytotoxicity outcomes upon spatial antigen separation
Chimeric antigen receptor T cells (CAR-T) are effective against cancer and autoimmunity, but the role of the endogenous T-cell receptor (TCR) remains unclear. Using TCRs as molecular barcodes, we traced anti-CD19 CAR-T clonotypes before and after infusion in patients with B-cell malignancies using single-cell sequencing. A cytotoxic phenotype, but not transcriptional responsiveness to tumor cells, correlated with CAR-T detection in vivo . To assess functional TCR contributions to CAR-T activity, we combined CAR transduction with orthotopic TCR replacement. Strong TCR signaling enhanced activation, but impaired CAR-mediated cytotoxicity when TCR and CAR antigens were presented by different target cells. Confocal imaging revealed preferential recruitment of cytolytic granules to the TCR synapse in cells simultaneously forming distinct CAR and TCR synapses. Thus, spatial antigen separation shapes receptor competition in CAR-TCR cells. Our findings have implications for therapeutic CAR-T design using defined TCRs to enhance cellular persistence or counteract tumor heterogeneity.
Open AccessAntigen receptor competition in CAR-TCR cells changes cytotoxicity outcomes upon spatial antigen separation
Chimeric antigen receptor T cells (CAR-T) are effective against cancer and autoimmunity, but the role of the endogenous T-cell receptor (TCR) remains unclear. Using TCRs as molecular barcodes, we traced anti-CD19 CAR-T clonotypes before and after infusion in patients with B-cell malignancies using single-cell sequencing. A cytotoxic phenotype, but not transcriptional responsiveness to tumor cells, correlated with CAR-T detection in vivo . To assess functional TCR contributions to CAR-T activity, we combined CAR transduction with orthotopic TCR replacement. Strong TCR signaling enhanced activation, but impaired CAR-mediated cytotoxicity when TCR and CAR antigens were presented by different target cells. Confocal imaging revealed preferential recruitment of cytolytic granules to the TCR synapse in cells simultaneously forming distinct CAR and TCR synapses. Thus, spatial antigen separation shapes receptor competition in CAR-TCR cells. Our findings have implications for therapeutic CAR-T design using defined TCRs to enhance cellular persistence or counteract tumor heterogeneity.
- Open Access
- 21 July 2022
- Published by Springer Nature in Nature Metabolism
- Vol. 4 (7) , 856-866
TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages
Successful elimination of bacteria in phagocytes occurs in the phago-lysosomal system, but also depends on mitochondrial pathways. Yet, how these two organelle systems communicate is largely unknown. Here we identify the lysosomal biogenesis factor transcription factor EB (TFEB) as regulator for phago-lysosome-mitochondria crosstalk in macrophages. By combining cellular imaging and metabolic profiling, we find that TFEB activation, in response to bacterial stimuli, promotes the transcription of aconitate decarboxylase (Acod1, Irg1) and synthesis of its product itaconate, a mitochondrial metabolite with antimicrobial activity. Activation of the TFEB–Irg1–itaconate signalling axis reduces the survival of the intravacuolar pathogen Salmonella enterica serovar Typhimurium. TFEB-driven itaconate is subsequently transferred via the Irg1-Rab32–BLOC3 system into the Salmonella-containing vacuole, thereby exposing the pathogen to elevated itaconate levels. By activating itaconate production, TFEB selectively restricts proliferating Salmonella, a bacterial subpopulation that normally escapes macrophage control, which contrasts TFEB’s role in autophagy-mediated pathogen degradation. Together, our data define a TFEB-driven metabolic pathway between phago-lysosomes and mitochondria that restrains Salmonella Typhimurium burden in macrophages in vitro and in vivo.
- 21 July 2022
- Published by Springer Nature in Nature Metabolism
- Vol. 4 (7) , 856-866
Open AccessTFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages
Successful elimination of bacteria in phagocytes occurs in the phago-lysosomal system, but also depends on mitochondrial pathways. Yet, how these two organelle systems communicate is largely unknown. Here we identify the lysosomal biogenesis factor transcription factor EB (TFEB) as regulator for phago-lysosome-mitochondria crosstalk in macrophages. By combining cellular imaging and metabolic profiling, we find that TFEB activation, in response to bacterial stimuli, promotes the transcription of aconitate decarboxylase (Acod1, Irg1) and synthesis of its product itaconate, a mitochondrial metabolite with antimicrobial activity. Activation of the TFEB–Irg1–itaconate signalling axis reduces the survival of the intravacuolar pathogen Salmonella enterica serovar Typhimurium. TFEB-driven itaconate is subsequently transferred via the Irg1-Rab32–BLOC3 system into the Salmonella-containing vacuole, thereby exposing the pathogen to elevated itaconate levels. By activating itaconate production, TFEB selectively restricts proliferating Salmonella, a bacterial subpopulation that normally escapes macrophage control, which contrasts TFEB’s role in autophagy-mediated pathogen degradation. Together, our data define a TFEB-driven metabolic pathway between phago-lysosomes and mitochondria that restrains Salmonella Typhimurium burden in macrophages in vitro and in vivo.